AxoGen, Inc.
AxoGen, Inc. (AXGN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AXGN · as of Sep 30, 2025
Ownership Breakdown
174
Institutional Holders
▲ 20 vs Q2
$732.83M
Total Inst. Value
▲ $300.89M vs Q2
53.18M
Shares Outstanding
freeFloat 97.85%
41.08M
13F Shares Held
▲ 1.27M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AXGN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FIRST LIGHT ASSET MANAGEMENT, LLC electromedical & electrotherapeutic apparatus | 5.81M | 12.73% | 12.73% | $103.57B | Nov 14, 2025 | ▲ 1.28M |
BLACKROCK, INC. electromedical & electrotherapeutic apparatus | 3.61M | 7.91% | 7.91% | $64.39B | Nov 12, 2025 | ▲ 108.9K |
VANGUARD GROUP INC electromedical & electrotherapeutic apparatus | 2.68M | 5.88% | 5.88% | $47.80B | Nov 7, 2025 | ▼ 51.0K |
MORGAN STANLEY electromedical & electrotherapeutic apparatus | 2.43M | 5.33% | 5.33% | $43.35B | May 27, 2026 | ▼ 80.9K |
ARROWMARK COLORADO HOLDINGS LLC electromedical & electrotherapeutic apparatus | 1.96M | 4.29% | 4.29% | $34.94B | Nov 14, 2025 | ▲ 332.5K |
SOLEUS CAPITAL MANAGEMENT, L.P. electromedical & electrotherapeutic apparatus | 1.73M | 3.79% | 3.79% | $30.80B | Nov 14, 2025 | ▲ 267.2K |
WASATCH ADVISORS LP electromedical & electrotherapeutic apparatus | 1.64M | 3.59% | 3.59% | $29.25B | Nov 14, 2025 | ▲ 205.6K |
BALYASNY ASSET MANAGEMENT L.P. electromedical & electrotherapeutic apparatus | 1.38M | 3.03% | 3.03% | $24.61B | Nov 14, 2025 | ▼ 551.5K |
ASSENAGON ASSET MANAGEMENT S.A. electromedical & electrotherapeutic apparatus | 1.29M | 2.83% | 2.83% | $23.00B | Oct 7, 2025 | ▲ 265.9K |
ARMISTICE CAPITAL, LLC electromedical & electrotherapeutic apparatus | 1.20M | 2.63% | 2.63% | $21.41B | Nov 17, 2025 | ▲ 88.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+4.12M shares4
New Positions
first time holders20
Decreased
−2.59M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.52M
+4.12M / −2.59M
Net new holders
+8
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AXGN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
10
Sell transactions
0.40
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Wendell Amy McBride director | May 8, 2026 | Sale | 1,647 | $42.60 | $70.2K | 93.8K | Form 4 ↗ |
JOHNSON JOHN director | May 7, 2026 | Sale | 11,050 | $43.26 | $478.0K | 0 | Form 4 ↗ |
Weiler Kathy Johnson director | May 7, 2026 | Sale | 16,344 | $44.09 | $720.6K | 0 | Form 4 ↗ |
Kemp Jens Chief Marketing Officer | May 7, 2026 | Sale | 4,000 | $43.44 | $173.8K | 72.5K | Form 4 ↗ |
Hartley Lindsey Marie CFO | May 7, 2026 | Sale | 573 | $43.67 | $25.0K | 65.1K | Form 4 ↗ |
Hartley Lindsey Marie CFO | May 7, 2026 | Sale | 478 | $43.67 | $20.9K | 62.8K | Form 4 ↗ |
Quackenbush Doris Sales VP | May 7, 2026 | Sale | 3,878 | $43.51 | $168.7K | 92.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
AxoGen, Inc. (AXGN) is primarily owned by institutional investors, who hold approximately 77.3% of total shares outstanding. Company insiders own approximately 2.15%, while retail and public investors account for the remaining 20.60%.
The largest institutional shareholder of AxoGen, Inc. is FIRST LIGHT ASSET MANAGEMENT, LLC, holding approximately 5.81 million shares — equal to 12.73% of outstanding shares — as of September 30, 2025.
A total of 174 institutional investors currently hold AXGN stock, with a combined institutional value of approximately $732,833,400 as of the most recent 13F filing period.
Frequently asked questions
AXGN ownershipAxoGen, Inc. (AXGN) is primarily owned by institutional investors, who hold approximately 77.3% of shares. The largest shareholder is FIRST LIGHT ASSET MANAGEMENT, LLC with a 12.73% stake. Company insiders hold 2.15%. Data sourced from SEC Form 13F as of September 30, 2025.